MedPath

Ayurvedic clinical trial on high cholesterol

Phase 3
Not yet recruiting
Conditions
Hyperlipidemia, unspecified. Ayurveda Condition: MEDOVRUDDHIH,
Registration Number
CTRI/2023/11/059428
Lead Sponsor
Vd Vaishali Shamrao Meshram
Brief Summary

The aim of study is toevaluate the clinical efficacy of Vatsakadi Vati with koshna jala in managementof Hyperlipidemia (Medovriddhi). To study the details of Vatsakadi Vati.To study in detailabout Medovriddhi according to Ayurvedic classics. To study in detail about Hyperlipidaemia according to modern medicine. The trial will be conductedon 50 patients showing anyone or more parameters of lipid profile i.e.,serum Cholesterol, serum Triglycerides, serum HDL, serum LDL, and serum VLDL, the range for the lipid profile will be decidedas per the American Journal of Lifestyle Medicine. Lipid profile will bechecked on the day patient enrollment. Medicine will be given for 60 days, atthe interval of 30 days patients will be assess the effect of therapy onobjective parameters. After 60 days of trial collected data of objectiveparameters will be statistically assess and conclusion will be drawn.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria
  • 1.Patient irrespective of age, sex, religion etc.of Hyperlipidemia.
  • 2.Patients with high blood lipid profile.Lipid profile showing any one or more of the following criteria was considered diagnostic of hyperlipidemia.
  • 3.Patients with controlled Type 2 diabetes mellitus and hypertensive patients with blood pressure within the normal limits.
  • 4.Obese Hyperlipidemic and Non-Obese hyperlipidemic Patients (BMI-18.50 to 40.00 kg/m2 as per New Updated WHO classification of BMI of 2004).
  • 5.Patient having Serum Total Cholesterol Level >200mg/dl.
  • 6.Patient having Serum LDL Cholesterol Level >130mg/dl 7.Patient having serum VLDL Cholesterol Level >40mg/dl.
  • 8.Patient having Serum HDL Cholesterol Level<40mg/dl.
  • 9.Patient having Serum Triglyceride Level >150mg/dl.
Exclusion Criteria
  • 1.Patients having a history of untreated thyroid disorder.
  • 2.Pregnant women & lactating mother.
  • 3.Chronic illness and infection like TB, CA and HIV infection.
  • 4.Patient is suffering with psychological disorders like anxiety, depression.
  • 5.Patient with Respiratory Diseases Complications, Coronary Heart Disease, Hepatic or Renal Disease etc.
  • 6.Drug induced Hyperlipidemia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Study to determine the effectiveness of Vatsakadi Vati in the dose of 500mg twice a day to maintain normal lipid profile level.30th day,60th day
Secondary Outcome Measures
NameTimeMethod
1.To study in detail about Medovriddhi according to Ayurvedic classics.2.To study in detail about Hyperlipidemia according to modern medicine.

Trial Locations

Locations (1)

R.A.Podar medical college, Mumbai

🇮🇳

Mumbai, MAHARASHTRA, India

R.A.Podar medical college, Mumbai
🇮🇳Mumbai, MAHARASHTRA, India
Dr Vaishali Shamrao Meshram
Principal investigator
9403109360
vaishalimeshram30@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.